These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35126353)

  • 1. Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.
    Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ
    Front Immunol; 2021; 12():782935. PubMed ID: 35126353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
    Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
    Front Immunol; 2018; 9():834. PubMed ID: 29867923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus.
    Ye L; Li L; Wan B; Yang M; Hong J; Gu W; Wang W; Ning G
    Stem Cell Res Ther; 2017 Apr; 8(1):90. PubMed ID: 28420440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
    Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
    Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
    Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
    Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
    Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
    Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
    Bayas A; Berthele A; Blank N; Dreger P; Faissner S; Friese MA; Gerdes LA; Grauer OM; Häussler V; Heesen C; Janson D; Korporal-Kuhnke M; Kowarik M; Kröger N; Lünemann JD; Martin R; Meier U; Meuth S; Muraro P; Platten M; Schirmer L; Stürner KH; Stellmann JP; Scheid C; Bergh FT; Warnke C; Wildemann B; Ziemssen T
    Ther Adv Neurol Disord; 2023; 16():17562864231180730. PubMed ID: 37780055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
    Abrahamsson SV; Angelini DF; Dubinsky AN; Morel E; Oh U; Jones JL; Carassiti D; Reynolds R; Salvetti M; Calabresi PA; Coles AJ; Battistini L; Martin R; Burt RK; Muraro PA
    Brain; 2013 Sep; 136(Pt 9):2888-903. PubMed ID: 23864273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in IL-21, IL-22, CCL2, and CCL4 serum cytokines after outpatient autologous transplantation for multiple sclerosis: A proof of concept study.
    Jaime-Pérez JC; Turrubiates-Hernández GA; López-Silva LJ; Salazar-Riojas R; Gómez-Almaguer D
    Clin Transplant; 2020 Dec; 34(12):e14114. PubMed ID: 33048389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
    Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J
    Cytotherapy; 2023 Dec; 25(12):1271-1276. PubMed ID: 37737765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
    Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):514-521. PubMed ID: 30538138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.
    de Oliveira GL; Ferreira AF; Gasparotto EP; Kashima S; Covas DT; Guerreiro CT; Brum DG; Barreira AA; Voltarelli JC; Simões BP; Oliveira MC; de Castro FA; Malmegrim KC
    Clin Exp Immunol; 2017 Mar; 187(3):383-398. PubMed ID: 28008595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained immunotolerance in multiple sclerosis after stem cell transplant.
    Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ
    Ann Clin Transl Neurol; 2022 Feb; 9(2):206-220. PubMed ID: 35106961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
    Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I
    Front Immunol; 2022; 13():798300. PubMed ID: 35197974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis.
    Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DD; Moore JJ; Massey JC
    Mult Scler; 2021 Nov; 27(13):2112-2115. PubMed ID: 33870788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis.
    Kasarełło K; Snarski E; Sulejczak D; Ciesielski T; Wiśniewska A; Wrzesień R; Cudnoch-Jędrzejewska A
    Arch Immunol Ther Exp (Warsz); 2021 Jun; 69(1):17. PubMed ID: 34181099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Ruder J; Dinner G; Maceski A; Berenjeno-Correa E; Müller AM; Jelcic I; Kuhle J; Martin R
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the T-helper cell 1/T-helper cell 2 balance of peripheral T-helper cells after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Mukai M; Bohgaki T; Kondo M; Notoya A; Kohno M
    Ann Hematol; 2001 Dec; 80(12):715-21. PubMed ID: 11797111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.